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Thyroid hormones influence brain development through regulation of gene expression mediated by
nuclear receptors. Nuclear receptor concentration increases rapidly in the human fetus during the
secondtrimester,aperiodofhighsensitivityof thebraintothyroidhormones. Intherat, theequivalent
period is the last quarter of pregnancy. However, little is known about thyroid hormone action in the
fetal brain, and in rodents,most thyroid hormone-regulated genes have been identified during the post-
natalperiod. To identifypotential targetsof thyroidhormone in the fetalbrain,we inducedmaternal and
fetal hypothyroidism bymaternal thyroidectomy followed by antithyroid drug (2-mercapto-1-methylimi-
dazole) treatment. Microarray analysis identified differentially expressed genes in the cerebral cortex of
hypothyroid fetuses on d 21 after conception. Gene function analysis revealed genes involved in the bio-
genesisofthecytoskeleton,neuronalmigrationandgrowth,andbranchingofneurites.Twentypercentof
the differentially expressed genes were related to each other centered on the Ca2 and calmodulin-acti-
vatedkinase (Camk4)pathway.Camk4was regulateddirectlybyT3 inprimary culturedneurons fromfetal
cortex, and the Camk4 protein was also induced by thyroid hormone. No differentially expressed genes
were recovered when euthyroid fetuses from hypothyroid mothers were compared with fetuses from
normalmothers.Althoughtheresultsdonot ruleoutaspecific contributionfromthemother,especiallyat
earlier stages of pregnancy, they indicate that themain regulators of thyroid hormone-dependent, fetal
brain gene expression near term are the fetal thyroid hormones. (Endocrinology 151: 810–820, 2010)
Thyroid hormones are extremely important for mam-malian brain development and maturation. They con-
trol awide range of developmental processes, such as neu-
ronal and glial cell differentiation and migration, axonal
myelination, and synaptogenesis. Accordingly, situations
leading to thyroid hormone deficiency during human de-
velopment may cause irreversible mental retardation and
variable degrees of neurological impairment (1, 2). The
effects of thyroid hormones are largely mediated through
the control of gene expression. The period of maximal
sensitivity of the rat brain to thyroid hormones spans the
first 2–3 wk after birth, and genes related to neuronal
migration, differentiation, and myelination are targets of
thyroid hormones during this period (1, 3). The equivalent
developmental period in humans extends from birth up to
1–2 yr of age.
There is also clinical and epidemiological evidence sup-
porting an earlier role of thyroid hormones in fetal brain
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development. For example, the classical syndrome of neu-
rological cretinism and the consequences of maternal hy-
pothyroidismandhypothyroxinemiaon the fetal brain are
thought to be due to thyroid hormone deficiency before
midgestation, most likely during the second trimester (4–
6).TheT3 receptor is alreadyexpressed in thehumanbrain
by the beginning of the second trimester of gestation (7),
before onset of fetal thyroid gland secretion, which occurs
around the 20th week of pregnancy. At these develop-
mental stages, increasing type 2 deiodinase activity favors
the selective accumulation of T3 in the developing cerebral
cortex (7, 8).
The second trimester of human pregnancy is roughly
equivalent to the second half of gestation in rodents (9–
11). In the rat, the nuclear receptor protein concentration
in the fetal brain is undetectable before embryonic d 13
(E13) and then increases reaching about 30% of adult
values by E17 (12). These values are maintained through-
out the rest of the fetal period and increase subsequently
after birth. Thyroid hormone content and secretion by the
fetal thyroid gland, and T4 and T3 concentrations in
plasma and brain are very low before E19 and increase
severalfold in brain up to termpregnancy. By E21, 58%of
adult concentrations of T4 and T3 are present in the fetal
brain (13). Before onset of thyroid gland function, mater-
nal thyroid hormones contribute significantly to the fetal
pool, and evenminor and transient deficiencies ofT4 in the
mother cause altered cerebral cortex development in the
fetus (14). Despite these observations, the rat fetal cere-
bellum at term was found unresponsive to thyroid hor-
mones in terms of gene expression (15). This is conceptu-
ally in disagreement with the above evidence. Although
the developmental timing of cerebral and cerebellar cor-
tices is different, it raises the possibility that the conse-
quences of thyroid hormone deprivation for fetal brain
development might be due to indirect causes unrelated to
the genomic actionsof thyroidhormone. Further efforts to
identify genes regulated by thyroid hormones in the fetal
brain have met with limited success (16, 17).
To understand the role of thyroid hormones on early
brain development, and to dissect the relative roles played
by the fetal and maternal hormones, knowledge of their
molecular targets in the fetal brain are needed. We have
analyzed the effects of maternal and fetal hypothyroidism
on global gene expression in the cerebral cortex of rat
fetuses at term pregnancy. We tried to answer the two
following questions. Do thyroid hormones influence gene
expression in the fetal cortex? And, what are the relative
roles of the maternal and fetal hormones? Our data rep-
resent the first systematic effort to identify molecular tar-
gets of thyroid hormone in the fetal brain, specifically in
the developing neocortex. We found that changes of gene
expressionwere not due to a nonspecific effect ofmaternal
hypothyroidism on the fetal brain, and rather, they were
correlated with the fetal thyroid hormones. The regulated
geneswerepresent innetworks involved innervous system
development and function, particularly influencing cell to
cell signaling and interaction, and cell movement and
maturation. In particular, the Ca2/calmodulin-acti-
vated kinase IV (Camk4)-cAMP-responsive element-
binding protein 1 (Creb1) pathway seems to play an
important role in thyroid hormone-dependent fetal ce-
rebral cortex development.
Materials and Methods
Animal handling
Young adult femaleWistar rats grown in our animal facilities
and weighing 250–300 g were used. Protocols for animal han-
dlingwere approvedby the local institutionalAnimalCareCom-
mittee and followed the rules of the European Union. Animals
were under temperature-controlled (222C) and light-controlled
(12-h light, 12-hdark cycle; lights onat 0700h) conditions andhad
free access to food andwater. All surgical interventionswere under
anesthesia by inhalation of 1.5–2% isoflurane (Esteve, Barcelona,
Spain) in O2 (0.9 liters O2/min).
To induce maternal and fetal hypothyroidism, the pregnant
damswere thyroidectomized (Tx) onE10 (the day of appearance
of the vaginal plug was E0) and given 0.02% 2-mercapto-1-
methylimidazole (MMI) (SigmaChemicalCo., St. Louis,MO) in
the drinking water until they were killed. To induce isolated
maternal hypothyroidism, the pregnant dams were Tx on E10
and given tap water as previously described (18). From the day
of thyroidectomy until killing, the pregnant dams were infused
with rat PTH (19) (PTH 1-84; Bachem H3086; Bachem, Tor-
rance, CA), 4 g/100 g body weight  d, and rat calcitonin (CT)
(20) (Bachem H3072), 1 g/100 g body weight  /d as described
(21). Both PTH and CTwere diluted in 0.1 M acetate buffer (pH
4.0) and simultaneously infused using osmotic minipumps
placed under the dorsal skin with a delivery ratio of 1 l/h  d
(Alzet model 2001, www.alzet.com, Cupertino, CA). The Tx
rats were also supplementedwith 0.16% Ibercal-D (Merck S. L.,
Madrid, Spain), which contains vitamin D3 (9.5 IU/100 ml
drinking water) and calcium pidolate (11.8 mg/100 ml). This
treatment prevented hypocalcemia and ensured a normal num-
ber of fetuses per litter (21). The dams of the control group were
sham operated and implanted with osmotic pumps containing
solvent. Serum PTH, CT, and calcium were measured as de-
scribed (21) in the rats used for microarray hybridizations at the
end of the experiment on E21 (see below). Control (n 10) and
TxMMI (n10) damshad similar concentrations (mean SD)
of circulating CT [control  0.13  0.08 ng/ml; TxMMI 
0.18 0.08 ng/ml, not significant (NS)], PTH (control 57.4
16.3 pg/ml; TxMMI  66.9  9.7 pg/ml, NS), and total cal-
cium (control  9.44  0.91 mg/100 ml; TxMMI  8.70 
1.16 mg/100 ml, NS). The brains of the pups were carefully
removed and the cerebral cortices dissected and immediately
frozen in liquid nitrogen. Thyroid hormones andTSHweremea-
sured as described (22).
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Microarray hybridization
Total RNA was isolated from the cerebral cortex of individ-
ual pups. The Trizol procedure (Invitrogen, Carlsbad, CA) was
followed, with an additional step of chloroform extraction.
DNA from the same sampleswas used to determine the sex of the
pups by PCR amplification of the Sry gene using as sense primer
5-CAGAGATCAGCAAGCATCTGG-3 and antisense primer
5-TCTGGTTCTTGGAGGACTGG-3 (23). The quality of
RNA was analyzed using a BioAnalyzer (Agilent, Santa Clara,
CA). Equal amounts of RNA from three pups of the same sex
from each litter were pooled, and 250 ng RNA was used as
template for the cDNA synthesis with the high-capacity cDNA
reverse transcription kit (Applied Biosystems, Foster City, CA).
The microarray assays were done using the Agilent platform
(Agilent whole rat genome array, 60-mer 4  44 slide format).
These arrays contain 41,012 probes representing 14,209 unique
genes and 20,061 nonmapped probes/expressed sequence tags
(based on annotations downloaded fromNCBI on September 2,
2008).
Analysis of the data from microarray
hybridizations
Analysis for differential expression was performed using the
Rplatform for statistical analysis (24) and several packages from
the Bioconductor project (25). The raw data were imported into
R and preprocessed using the half method for background cor-
rection and the quantile method for normalization. Probes with
expression level below the detection control probe in all sam-
ples were removed. To identify differentially expressed genes,
we used the limma package (26) that fits a gene-wise linear
model, allowing us to account for different experimental and
technical factors. Experimental factors included sex and treat-
ment and a batch effect to account for technical variation.
Correction for multiple testing was accomplished by control-
ling the false discovery rate using the method from Benjamini
and Hochberg (27).
Pathway analysis
The Ingenuity Pathway Analysis (Ingenuity Systems, www.
ingenuity.com) was used to identify the biological functions
and/or diseases that were most significantly represented in the
data set. The program uses the Ingenuity’s knowledge database
containing large amounts of individually modeled relationships
between genes obtained from the literature. Data containing dif-
ferentially expressed genes and the corresponding expression
values were uploaded into the application. Interactions between
molecules of interest with other molecules in the database were
identified as network eligiblemolecules (focus genes) andused to
construct functional regulatory networks. Networks of these fo-
cus genes were then algorithmically generated based on their con-
nectivity. Networks are scored based on the number of focus genes
they contain. The network score is based on the hypergeometric
distributionandiscalculatedwiththeright-tailedFisher’sexact test.
The score is thenegative logof thisPvalue.Thehigher the score, the
lower is the probability of finding the observed number of focus
genes in a given network by random chance.
Functional analysiswasperformedon thesenetworks to iden-
tify the biological functions and/or diseases that were most sig-
nificant to the genes in the network. Fisher’s exact test was used
to calculate a P value to determine the probability that each
biological functionand/ordisease assigned to thatnetwork isdue
to chance alone.
We also performed a promoter analysis using the BiblioSphere
PathwayEdition version7.20 (Genomatix Software,Munich,Ger-
many; http://www.genomatix.de). This software integrates litera-
ture mining (from published abstracts) and annotation analysis
(Gene Ontology). In addition, genes found to be co-cited with a
transcription factor are analyzed with Genomatix MathInspector
for transcription factorbindingsites in thepromotersof theco-cited
genes (28).
Primary cultures
All media were purchased from Invitrogen. The cerebral cor-
tices were dissected from E17 normal rat fetuses in Hanks’ bal-
anced sodium salt solution (HBSS), without Ca2 and Mg2,
supplemented with 1 mM sodium pyruvate and 10 mM HEPES
(pH 7.4). The tissue was disaggregated by passing through a
0.9-mm syringe, rinsed in HBSS/pyruvate/HEPES, and resus-
pended in serum-free culture medium (neurobasal medium sup-
plemented with 2% B27, 0.5 mM glutamine, 10 U/ml penicillin,
and 10 U/ml streptomycin), before seeding on poly-L-ornithine-
coated 12-well multiwells (Sigma) (2.5  105 cells per well).
After 4 d, the cells were incubated 24 or 48 h in the samemedium
without B27 supplement before adding 5 nM T3 (Sigma). Control
cultures without T3 added were incubated in parallel. To examine
the response toT3 in the presence of inhibition of protein synthesis,
cycloheximide (Sigma) was added to the cultures at a final concen-
trationof8g/ml30minbeforeT3, and thecellswereharvested6h
after T3 addition. All assays were run in triplicate.
Western blotting
Proteins were extracted from neuronal cultures in 0.15 M
NaCl, 10% glycerol, 0.0015 M MgCl2, 0.001 M EDTA, 0.1 M
NaF, 1% Triton X-100, 1% Na deoxycholate, 0.1% SDS, 0.05
M HEPES (pH 7.4) to which the following protease inhibitors
were added: 0.1 M Na3VO4, 0.025 M -glycerol-P, 0.01 mg/ml
leupeptin, 0.01 mg/ml aprotinin, and 0.001 M phenylmethylsul-
fonyl fluoride. Thirty micrograms of each sample were run in
10%acrylamide gels. ForWesternblotting,weused anti-Camk4
antibody (1:1000; Sigma) and antirabbit IgG (1:5000; Santa
Cruz Biotechnology, Santa Cruz, CA) for secondary antibody;
anti--tubulin (1:5000; Abcam, Cambridge, MA), and anti-
mouse IgG (1:5000, Santa Cruz). The blots were developed in
0.275 mM pcumaric acid, 1.25 mM luminol, 36% H2O2, 0.1 M
Tris-HCl (pH 8.8).
Real-time PCR
Real-time PCRwas performed on a 7900HT Fast Real-Time
PCRSystem (Applied Biosystems). A cDNAaliquot correspond-
ing to 5 ng of the starting RNA was used. Assay-on Demand
TaqMan primers and TaqMan Universal PCRMaster Mix, No
AmpErase UNG,were purchased fromApplied Biosystems. The
PCR program consisted in a hot start of 95 C for 10 min, fol-
lowed by 40 cycles of 15 sec at 95 C and 1 min at 60 C. Assays
were performed in triplicate, using the 18S gene as internal stan-
dard and the 2Ct method for analysis.
Forbiological confirmationof themicroarray results,weused
RNA from pups of different litters from those used for microar-
ray hybridization. As startingmaterial for these experiments, we
used pooled RNA from three fetuses of each litter and compared
the pools of different litters. In addition, some probes were con-
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firmed by analyzing a large number of RNA samples of individ-
ual fetuses from several litters. For analysis of gene expression in
cultured cells, we used RNA isolated from about 5 million cells
in triplicate. Significance of differences between experimental
groups was calculated by the Student’s t test when two groups
were compared. When comparing more than two groups, we
performed one-way ANOVA and the Tukey post hoc test
(GraphPad Software, San Diego, CA; www.graphpad.com).
Results
Models of maternal and fetal hypothyroidism
We validated the models of maternal and fetal hypo-
thyroidism used in this work by measuring TSH in the
maternal and fetal serum and T4 and T3 in the maternal
serum and the fetal cortex (Fig. 1). For these determina-
tions,weusedadifferent groupof animals from thoseused
for microarray analysis, but similarly treated. Tx dams
showed increased TSH and decreased T4 and T3, as ex-
pected. However, the fetuses from Tx rats had normal
serum TSH and cerebral cortex T4 and T3. Tx dams
treated with MMI showed similar changes in maternal
serum as Tx. The pups from these rats were also hypo-
thyroid, with elevated TSH and decreased cortex T4 and
T3 (Fig. 1). Therefore, thyroidectomy of the dams resulted
in maternal hypothyroidism, whereas additional treat-
ment with MMI resulted in combined maternal and fetal
hypothyroidism.
Changes in gene expression in the fetal
cerebral cortex induced by maternal and
fetal hypothyroidism
To identify candidate genes regulated by thyroid hor-
mones in the fetal cerebral cortex, we first used the model
of combined maternal and fetal hypothyroidism. Mater-
nal serum TSH, T4, and T3 were again measured in this
group as an added control for this experiment. T4 in the
control dams (n  17) was 18.2  7.4 ng/ml and was
reduced by about 95% in the hypothyroid dams (T4 
0.8  0.1 ng/ml, P  0.0001; n  17). Serum T3 in the
control dams was 0.416  0.109 ng/ml and was reduced
by about 87% in the hypothyroid dams (0.035  0.003
ng/ml, P 0.0001). Circulating TSH in the control dams
was 4.73  0.89 ng/ml and was increased 6-fold in the
hypothyroid dams (28.165.3 ng/ml,P0.0001). From
this group, 10 control and10hypothyroid litters of similar
size (between nine and 12 pups) were selected.
For microarray hybridizations, we started from RNA
pools of three males from each of five control and five
hypothyroid litters and of three females from an equal
number of different litters. In a previousworkon the effect
of thyroid hormone in the developing postnatal cerebel-
lum (29), it was shown that differential gene expression
was influenced by sex. Therefore, to analyze a possible
effect of sex in the expression of genes in the fetal cerebral
cortex, we added the sex factor, in addition to treatment,
to the statistical model. The resulting distribution of P
values was flat, and only a few probes were expressed
differently inmales comparedwith females.Most of them
correspond to genes linked to the sex chromosomes (see
supplemental Data 1, published as supplemental data on
TheEndocrine Society’s JournalsOnlineweb site at http://
endo.endojournals.org), and there was no difference in
expression of these genes between hypothyroid and con-
trol fetuses (supplemental Table 1). Therefore, for statis-
tical analysis of the arrays, we used all the data from the
10 control and 10 hypothyroid litters, without further
taking into account the sex of the pups.
Using a statistical cutoff of Padjust  0.01, we obtained
1252 differentially expressed probes (552 unique genes), of
which 583 probes (244 genes) were up-regulated and 669
(308 genes) down-regulated by hypothyroidism (the com-
plete list is provided in supplemental Table 1). From this list,
428 genes were identified in the Ingenuity knowledge data-
baseandused toconstruct functionalnetworks.Thedetailed
listof individualgenes included in thesenetworks isprovided
insupplementalTable2.Thebiological functionsassignedto
the most significant networks correspond to cell-to-cell sig-
naling and interaction, cellular assembly and organization,
cellular function, nervous systemdevelopment and function,
cellularmovement, andorgandevelopment.Adetailed anal-
ysis for some functional subcategories revealed genes in-
volved in the biogenesis of cytoskeleton, migration, growth,
and branching of neurites (Table 1).
A prominent role of the Camk4 and Creb1 pathway
was suggested by the finding that 56 genes contained
FIG. 1. Models of maternal and fetal hypothyroidism: concentrations
of serum TSH in the maternal and fetal compartments and of T4 and T3
in the maternal serum and fetal brain. C, Control dams; MMI, TxMMI
dams. Number of animals was 5 for each value. One-way ANOVA
indicated significant differences (P  0.001) between C and either Tx
or MMI for the maternal values and between MMI and either C or Tx
for the fetal values. All other comparisons were NS. All units are
nanograms per milliliter.
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TABLE 1. Significant processes affected by fetal hypothyroidism in the cerebral cortex
Function annotation P value Molecules No. of molecules
Biogenesis of cytoskeleton 8.40  103 CALR, CNN1, CSRP1, DYNLL1, KRAS, NEFH,
NEFL, NEFM, PACSIN2, PAFAH1B1
10
Quantity of filaments 2.50  104 FMOD, FN1, KRAS, NEFH, NEFL, NEFM,
PAFAH1B1, SERPINH1, TPM1
9
Assembly of neurofilaments 2.52  105 NEFH, NEFL, NEFM 3
Clustering of neurofilaments 2.52  105 NEFH, NEFL, NEFM 3
Organization of neurofilaments 1.26  103 NEFH, NEFL, NEFM 3
Dissociation of neurofilaments 2.52  105 NEFH, NEFL, NEFM 3
Accumulation of neurofilaments 9.86  105 NEFH, NEFL, NEFM 3
Size of axons 9.86  105 NEFH, NEFL, NEFM 3
Arborization of dendrites 1.26  103 NEFH, NEFL, NEFM 3
Branching of neurites 1.65  103 KLF9, NEFH, NEFL, NEFM, NOS1, SLIT1, SLIT2 7
Bifurcation of dendrites 2.94  102 NOS1 1
Growth of neurites 9.40  104 CREB1, FN1, HAP1, KRAS, MAPK1, SLIT1,
SLIT2
7
Cell movement of normal cells 2.20  102 C2, CALR, CCND1, CD86, CTSS, FLT1, FN1,
GCNT1, GNAS, HIST1H1T, HRH3, HSPD1,
IFNAR1, IL12A, ITGAE, LCP2, LTB,
MADCAM1, MAPK1, NOV, PAFAH1B1,
PNOC, RGS3, SLIT2, TGFB2
25
Cell movement of neurons 1.72  102 PAFAH1B1, RGS3, SLIT2 3
Positioning of cells 2.31  104 LTB, PAFAH1B1, PVRL2, SLIT1, SLIT2 5
Positioning of neurons 5.79  103 PAFAH1B1, SLIT1, SLIT2 3
Guidance of axons 5.12  103 ANK3, ARX, CHN1 (includes EG:108699),
CNTN4, MAPK1, SEMA3B, SLIT1, SLIT2,
TGFB2
9
Guidance of thalamocortical axons 4.97  103 SLIT1, SLIT2 2
Chemorepulsion 1.06  102 FLT1, SEMA3B, SLIT2 3
Migration of neural crest cells 2.69  102 ACAN, FN1, SEMA3C, SLIT2 4
Recognition of neurons 8.12  103 OPCML, SLIT2 2
Stratification of cerebral cortex 8.61  104 DAB1, PAFAH1B1 2
Proliferation of cerebral cortex cells 8.02  104 ADCYAP1R1, CREB1 2
Development of cortical plate 2.94  102 DAB1 1
Depolarization of neurons 7.20  103 ADCYAP1R1, CACNG8, NTS 3
Depolarization of pyramidal neurons 2.94  102 CACNG8 1
Transport of endosomes 1.98  102 HAP1, SNX16, SQSTM1 3
Formation of clathrin-coated pits 2.53  103 ANXA6, PICALM 2
Exocytosis 1.36  102 ATP2A2, EXOC7, HRH3, RPH3AL, SNAP23,
SYT2, SYTL5, VAMP4
8
Function of organ 2.90  103 CALR, CREM, FLT1, GREM1, HOMER1,
SOSTDC1, TXNIP
7
Binding of cells 1.76  102 ADAM15, ADAM1A, ADIPOR2, CALR,
CD86, CNTNAP1, F3, FN1, GCNT1, GNAS,
GPC1, HAS2, HIST1H1T, HS3ST1, ITGAE,
LCP2, RGS3, SEMA3B, SERPINF1,
SERPINF2, TGFB2
21
Invasion of cells 1.06  102 CALR, CCND1, ENTPD5, EZH2, FBLN5, FLT1,
FN1, GPI, HAS2, JUNB, KLF4, MAPK1,
MYCN, NOV, ODC1, PICALM, SERPINF2,
SLC9A3R1, SLIT2, SPDEF, WISP1
21
Neurological process of mice 4.14  103 ADCY8, ADRBK2, AGA, CALB1, CANX,
CREB1, CREM, DBP, DYRK1A, GNB1 liter,
GRK5, HOMER1, HSD11B2, NOS1, NTS,
PNOC
16
Long-term memory of rats 4.97  103 CREB1, CREM 2
Circadian rhythm 4.89  103 CREB1, CREM, DBP, HTR7, JUNB, MAPK1 6
Analgesia of mice 1.38  102 ADCY8, ADRBK2, NOS1, NTS 4
Neurotransmission 2.96  105 HAP1, HOMER1, HTR7, MAPK1, PAFAH1B1,
PNOC, ROM1, SLC17A7
8
Neurogenesis 5.46  104 CNTN4, CREB1, DYRK1A, HAP1, PAFAH1B1,
SLIT1, SLIT2, TGFB2
8
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Creb1-binding sites in their promoter region (supplemen-
tal Table 3). BiblioSphere Pathway analysis disclosed that
82 genes (about 15% of all differentially expressed genes)
were related to each other centered onCamk4/Creb1. Fig-
ure 2 shows these relationships, by integrating published
data on genes regulated directly or indirectly by the tran-
scription factor Creb1, which is activated by Camk4-in-
duced phosphorylation.
PCR confirmation
Real-time PCR was used for confirmation of gene ex-
pression changes induced by hypothyroidism. These ex-
periments were performed in biological replicates, i.e. in a
different group of pups than those used for the arrays but
obtained from similarly treated dams.We selected the tar-
get genes on the basis of several criteria, namely their rel-
ative abundance, expression changes above 1.6-fold,
known involvement in developmental processes, and
availability of predesigned TaqMan probes. We followed
twoapproaches,with similar results. In the first approach,
six control and sevenhypothyroid litterswere individually
analyzed using cortex RNA pools from three randomly
selected pups of each litter (Fig. 3A). In this approach,
individual variability among the fetuses of the same litter
was averaged by analyzing a single pool from each litter.
Figure 3B shows the results of PCR using an alternative
approach with cortex RNA from individual fetuses. For
this analysis, we employed six fetuses from each of four
control litters and six fetuses from three hypothyroid lit-
ters, making a total of 24 control and 18 hypothyroid
fetuses. Sixteen genes of 20 were confirmed as being dif-
ferentially expressed in the hypothyroid fetuses, with the
largest effect found on Camk4. Differences in expression
of fourgenes (three fromtheup-regulated set andone from
the down-regulated set) were not significant, although the
mean fold changes were in the same direction as in the
arrays. Mean fold changes SE for these four genes were
as follows: Prom2, 1.7  0.3 (P  0.08); C8g, 1.6  0.4
(P0.21);Cirbp, 1.20.2 (P0.34); andHs3st1, 0.8
0.1 (P  0.21).
Relative roles of the maternal and fetal thyroid
glands
The effects of hypothyroidismon fetal gene expression,
as analyzedwith the previous experimentalmodel of com-
bined maternal and fetal hypothyroidism, might be a di-
rect consequence of thyroid hormone action or secondary
to othermetabolic alterations induced bymaternal and/or
fetal hypothyroidism. Itwas also possible that the replace-
ment treatment with CT and PTH might have influenced
the expression of sensitive genes. To check the effect of
these factors, we analyzed gene expression in the cerebral
cortex of euthyroid fetuses from Tx mothers. Tx of the
dams was performed on E10. Circulating T4 in the Tx
dams of this groupwas one order ofmagnitude lower than
in the control dams (1.6  0.5 vs. 16.4  3.8 ng/ml, P 
0.0001). Microarray hybridizations were performed by
comparing E21 fetal cerebral cortices derived from 12
control dams and 12 hypothyroid dams. Analysis of the
FIG. 2. Interrelations of differentially expressed genes centered on
Camk4-Creb1. This analysis was performed using the BiblioSphere
Pathway Edition version 7.20 (Genomatix Software). The analysis
integrates literature mining (from published abstracts) and annotation
analysis (Gene Ontology). Genes found to be co-cited with a transcription
factor were analyzed using Genomatix MathInspector for transcription
factor binding sites in the promoters of the co-cited genes. Those co-
citations verified as functional (such as “gene A …function word…
gene B”) by inspection of the pertinent PubMed abstracts were
represented by connection lines between the genes. Arrowheads at the
end of a connecting line symbolize the type of functional relationship
between the connected genes (arrowheads indicate activation, and
blocked arrowheads indicate inhibition). The dotted line indicates that a
gene encoding a transcription factor is connected to a gene known to
contain a binding site for this transcription factor in its promoter. Hand-
annotated gene-gene relationships are indicated by a circle in the center
of the connection line.
FIG. 3. Confirmation by real-time PCR of the effect of hypothyroidism on
gene expression in the fetal cortex. Expression data were normalized by
giving a value of 1 to the mean value of controls. A, Assays were done in
pools from three fetuses of each litter. Six control litters (white bars) and
seven hypothyroid litters (black bars) were analyzed for each gene target.
B, Assays were done with individual fetuses, using six fetuses per litter.
Four control litters (24 individual samples) and three hypothyroid litters
(18 individual samples) were analyzed for each target gene. Significance
of differences was calculated by the Student’s t test. *, P 0.05; **, P
0.01; ***, P 0.001.
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microarray data revealed that there were no changes of
gene expression below a significance level of P  0.05
(not shown). To substantiate the lack of effect of iso-
lated maternal hypothyroidism, we measured the ex-
pression of nine of the genes shown above to be most
sensitive to maternal and fetal hypothyroidism (Fig 4).
There was no change in expression of these sensitive
genes, indicating that in the presence of maternal hy-
pothyroidism, the fetal hormones secreted during the
last days of gestation are able to maintain thyroid hor-
mone-dependent cerebral cortex gene expressionwithin
normal levels.
Direct effect of T3 on primary cultures of fetal
cortex neurons
To examine the direct responsiveness to T3, we used
primary neuronal cultures obtained from the cerebral cor-
tex of normal E17 fetuses. The cells were incubated in the
presence or absence of T3 tomeasure the expression of the
same group of 16 genes shown in Fig. 3 (Fig. 5). In pre-
liminary experiments 5 and 50 nM T3 gave similar results
24 h after addition to the cultures, so that in subsequent
experiments, we used 5 nM T3. A significant response was
found for Camk4, Nefm, Sema3c, Grem1, Pnoc, Nov,
Slc7a3, and Gprc5 (Fig. 5, upper panel). No effect of T3
was found on Dbp, Pdia4, Nudt5, Cyp1b1, Kcnj14,
Hist1h2bh,Usp48, andNgb, although the change for the
latter was in the expected direction. In another experi-
ment, using adifferent preparationof cells,we checked the
response at 24 and 48 h after T3 addition. The effect on
Camk4,Grem1,Nefm, andNovwas highest at 48 h. For
Pnoc and Slc7a3, the maximal effect was obtained at 24 h
(Fig. 5, lower panel).
Addition of T3 to the neurons in primary culture also
induced the accumulation of the Camk4 protein, with a
maximal effect at the highest time point studied (72 h,
Fig. 6, upper panel). Finally, to analyze whether the
effects of T3 were direct or required the synthesis of
intermediate proteins, we analyzed the effect of T3 6 h
after addition in the presence or the absence of cyclo-
heximide (Fig. 6, lower panel). Of the genes showing a
clear effect of T3 in the primary cultures, only Camk4
was induced in the presence of cycloheximide. Camk4
expression was increased significantly by T3 already 6 h
after addition to the cultures. Cycloheximide had a
mRNA-stabilizing effect, because Camk4 mRNA was
also increased in the presence of this drug. However,
cycloheximide did not prevent a further increase when
T3 was also added. For other genes, as shown forNefm,
no effect of T3 was observed at 6 h, and therefore it was
FIG. 4. Lack of effect of maternal Tx on gene expression in the fetal
cerebral cortex on E21. Fetuses were obtained from Tx dams, so that
the fetuses remained euthyroid, whereas the mother was hypothyroid.
The RNA substrate for PCR was prepared from pools of three fetuses
from the same litter. Litters from five control (white bars) and five Tx
(black bars) dams were analyzed.
FIG. 5. Stimulation of gene expression by T3 in primary neuronal cultures
from E17 fetal cerebral cortex. T3 (5 nM) was added to the cultures, and
expression of the indicated genes was measured by real-time PCR 24 h
(gray bars) and 48 h (black bars) after T3 addition. The values are
expressed as fold change over controls, giving a value of 1 to the cells
incubated in the absence of T3. One-way ANOVA with Tukey test for all
comparisons: *, P 0.05; **, P 0.01; ***, P 0.001.
FIG. 6. Upper panel, Stimulation of Camk4 protein synthesis at
different times after addition of 5 nM T3 to the cultures. Control
marker is -tubulin (-tub). Lower panel, Effect of cycloheximide on
Nefm and Camk4 mRNA induction by T3. Cells were incubated with T3
for 6 or 24 h with T3, as indicated, or 6 h with cycloheximide alone (C)
or with T3 (C  T3). One-way ANOVA: *, P  0.05; ***, P  0.001.
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not possible to analyze the effect of cycloheximide.
Longer incubation times in the presence of cyclohexi-
mide were not tested.
Discussion
Previous studies on thyroid hormone action in the
fetal brain
Despite extensive work on the actions of thyroid hor-
mones in brain development there are still many uncer-
tainties as to how thyroid hormones influence maturation
of the fetal brain, and to related questions such as the
relative roles of the maternal and fetal thyroids, or the
timing of action of thyroid hormones. One of the difficul-
ties in approaching these problems is the almost complete
lack of knowledge on the molecular targets of thyroid
hormones in the developing fetal brain. Some years ago it
was concluded that the fetal rat brain is not sensitive to
thyroid hormones in terms of gene expression (15). How-
ever, the patterns of T3 accumulation, and of T3 receptor
and deiodinase expression in the human and rodent brain
suggest otherwise. During the second trimester of human
pregnancy there is a selective accumulation of T3 in the
cerebral cortex. There are also many clinical and epide-
miological data indicating that thyroid hormones exert
important role in brainmaturationbeforemid gestation in
humans (corresponding to the endof the fetal period in the
rat) as evidenced by neurological cretinism and related
syndromes (2, 9).
Previous studies have identified target genes of thyroid
hormones during the postnatal period in the rat (1) or in
adult animals (31), but studies focused on the fetal brain
have led to only fragmentary information. In fact, stud-
ies using models of maternal and fetal hypothyroidism
as employed in this work have identified genes that were
sensitive to thyroid hormones in the postnatal brain but
insensitive in the late fetal brain (32). Other studies have
shown quantitative changes in specific mRNAs or pro-
teins after maternal hypothyroidism or thyroid hor-
mone treatment (17), but a global analysis of the effect
of thyroid hormones on the fetal brain has not been
made.
Limitations of the microarray approach
It is often pointed out that a major difficulty in studies
of gene expression in the brain is the high cellular and
molecular complexity of brain tissue, precluding the re-
covery of cell type-specific information. A recent analysis
on the human brain transcriptome suggests that it is pos-
sible to detect significant expression levels of genes with
restricted expression in specific cells using total brain
RNA (33). In our study, we detected the expression of
genes of restricted expression in the layer I-specific, Cajal-
Retzius (CR) cells, such asEbf3 (CR over non-CR expres-
sion 2342/9) (34), indicating that the use of a complex
tissue such as the cerebral cortex was not a major imped-
iment to isolate thyroid hormone-sensitive genes. A dif-
ferent but related question is whether it is possible to
detect cell-restricted changes of expression of genes be-
ing expressed in different cell types. Thus, we did not
recover Rln as a differentially expressed gene, as re-
ported previously (35), suggesting that nonregulated
expression in non-CR cells masked the changes in the
CR cells (Rln expression in the CR cells over non-CR
cells  15,546/979) (34). Therefore, the methodology
used in this work allowed the identification of genes
regulated by thyroid hormones throughout the cortex
or in major cell populations but had limitations to re-
cover cell-specific responses. This limitation should be
kept in mind when analyzing the possible contribution
of the maternal hormones to gene expression in the fetal
brain.
Correlation between morphological alterations
of hypothyroidism and significantly affected
pathways
Wehave identified a relatively large number of genes of
altered expression in the fetal cerebral cortex as a conse-
quence of hypothyroidism. Ingenuity pathway analysis
disclosed that nervous system development and function,
cell to cell signaling, and posttranslational modifications
were among the pathways significantly affected. More
specifically, among the relevant functions affecting the de-
velopment of the cerebral cortex were those related to cell
movement and positioning, assembly of neurofilaments,
and branching of neural processes. Although this conclu-
sion falls within what should be expected from the mor-
phological effects of hypothyroidism, the data provide a
molecular framework for the known effects of thyroid
hormone on cell migration, cerebral cortex layering, and
branching of dendrites.
Significance of Camk4 induction
We found a prominent role for theCamk4-Creb1 path-
way and downstream targets (36) in the action of thyroid
hormone in the fetal cortex.Camk4waspreviously shown
to be induced by T3 in rat fetal telencephalic cultures (37,
38) and inmouse embryonic stem cells (39). Developmen-
tal expression of Camk4 correlates with periods of neu-
ronal differentiation and apoptosis (40) and has been im-
plicated in brain-derived neurotrophic factor (BDNF)
action (41). Induction of Camk4 and Creb1 downstream
targetsmay represent an important process in thyroid hor-
Endocrinology, February 2010, 151(2):810–820 endo.endojournals.org 817
mone action in the fetal cortex, because it should facilitate
Ca2 regulation of dendritic growth (42). The transcrip-
tional activity of the nuclear T3 receptor is enhanced by
Camk4 (44). Therefore, induction of Camk4 may poten-
tiate T3 signaling, a process that might be highly relevant
in the developing brain, at stages when the concentrations
of T3 and its nuclear receptor are still low. Potentiation of
T3 receptor signalingbyCamk4maybedue todirect phos-
phorylation of coactivators (44) or by disrupting apo-re-
ceptor repression through the silencing mediator for reti-
noic acid and thyroid hormone (SMRT) corepressor and
histone deacetylases. This lattermechanismhas beendem-
onstrated after synaptic activity-dependent Ca2 activa-
tion of Camk4 (45) andmay potentiate thyroid hormone-
dependent stimulation of synaptogenesis. Based on these
data, we propose that Camk4 regulation is an essential
part of an amplifying mechanism for T3 action in the fetal
brainat stageswhereboth the concentrationofT3and that
of receptor are still low. In support of this proposal, a
thyroid hormone-responsive element has been identified
in the Camk4 gene promoter (39), and as we show here,
the stimulation by T3 in cultured neurons was direct.
Lack of effect of maternal hypothyroidism
It might be argued that the genomic effects observed as
a consequence of hypothyroidism in the fetal brain are
nonspecific consequencesofhypothyroidism, especiallyof
the mother, and would not reflect a direct disruption of
thyroid hormone signaling. Direct actions of T3 are sup-
ported by its effects on primary cultured neurons, and at
least one of the gene targets, Camk4, was regulated di-
rectly at the transcriptional level.Thenonresponsive genes
might represent downstream actions of T3 or permissive
actions of the hormone requiring cooperation with addi-
tional factors present in vivo and absent from the cultures.
In addition, we did not find significant changes of gene
expression in the cerebral cortex of euthyroid fetuses born
from Tx mothers. In this experiment, the fetuses had
grown in a hypothyroid milieu from E10 to at least the
onset of fetal thyroid secretion on E17–E18. The subse-
quent accumulation of T3 in the fetal brainwas effective in
maintaining normal gene expression on E21. Therefore,
we may conclude that changes of gene expression in the hy-
pothyroid fetal cortex are not due to general nonspecific ef-
fects of hypothyroidism. This conclusion agrees with previ-
ous data showing that the metabolic effects of maternal
thyroidectomy during the second half of gestation are com-
pensated by a normally functioning fetal thyroid gland (46).
Relative roles of the maternal and the fetal
thyroid hormones
The fact that fetuses from Tx mothers showed no
changes in cortex gene expression suggests that the fetal
thyroid hormones are the main regulators of fetal brain
gene expression at term. This is not to say that maternal
hypothyroidism is irrelevant in gestation. It is known that
deficient contribution ofmaternal hormones to the fetus is
compensated by increased fetal thyroid secretion (13). In
line with this, TSH has been reported to be increased in
fetuses from hypothyroid dams at term gestation (46, 47),
although other authors found that it was unchanged (30,
43). We found that fetuses from Tx dams had normal
serum TSH and brain T4 and T3 concentrations on E21,
indicating efficient compensation by the fetal thyroid
gland. Despite these observations, maternal hypothyroid-
ism from E16 to birth induced by thyroidectomy leads to
structural defects of the cerebral cortex and the hippocam-
pus of the offspring (21). The molecular basis for these
alterations remains unknown and may consist of subtle
actions, probably restricted to specific cellular groups.
Maternal thyroid hormones should also be important at
earlier stages of gestation and especially before onset of
fetal thyroid hormone secretion (16, 17) or in situations of
isolated fetal hypothyroidism. The experimental approach
and themolecular targetsdescribed in thispaperarevaluable
tools to investigate this issue in more detail.
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